Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Merck & Co. claims FPTase inhibitors for cancer

Jan. 17, 1997

Anticancer/antimetastatic agents from Sankyo

Jan. 17, 1997

Fluasterone enters phase I as breast cancer prevention agent

Jan. 16, 1997

First launch for AccuSite

Jan. 16, 1997

Novel antitumor agents from Kyowa Hakko

Jan. 16, 1997

Protein tyrosine kinase inhibitors from Kyowa Hakko

Jan. 16, 1997

Gene Logic/Baylor prostate cancer collaboration

Jan. 15, 1997

FDA clears antimetastatic carbohydrate compound for human trials

Jan. 15, 1997

AEterna accelerates anticancer clinical program

Jan. 15, 1997

New MDR modulators disclosed by Vertex

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...